slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 230,461-230,490
Pages 10,126
Rows per page 30
Component
230,461-230,490 of 303,780
08
The slide presents experimental evidence (Western blot) supporting the mechanism of action for NXP800 in ARID1a-deficient cancer cells.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
The slide presents three separate line charts showing tumor growth inhibition over time for different cell lines (RL95-2, KLE, SNG-M).Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
12
The slide uses a patient selection strategy based on ARID1a mutation status.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
13
The slide uses a split-column layout to contrast two phases of a clinical trial.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
14
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · ProblemLoop · Voice Of Customer1 hit
15
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
16
The charts are kinome dendrograms (KinomeScan style).Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
18
Includes a biological pathway diagram and an IC50 dose-response curve.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Voice Of Customer1 hit
19
Data shows tumor regression in treated groups vs growth in control groups over 27 days.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Voice Of Customer1 hit
20
Includes two distinct experimental setups: in vitro proliferation assays and in vivo bioluminescence imaging (BLI) tumor growth studies.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Voice Of Customer1 hit
21
The table segments indications by Squamous cell prevalence and NF2 mutation prevalence.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Voice Of Customer1 hit
22
Clinical trial identifier NCT05873686 is provided.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Traction1 hit
24
The slide uses a chevron-based list layout to categorize key highlights.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
25
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
02
Oscar Health | Investor Conference Presentation Deck | 9 slidesOscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Humble Origins1 hit
03
Oscar Health | Investor Conference Presentation Deck | 9 slidesOscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Humble Origins1 hit
04
The slide uses a hub-and-spoke style diagram to show the central brand 'Oscar' connecting to two distinct business lines.Oscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Rising SuccessLoop · Quick Win Big Bet1 hit
05
The slide uses a dual-flywheel framework to represent the integration between member engagement and provider collaboration.Oscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Rising SuccessLoop · Quick Win Big Bet1 hit
06
Includes a disclaimer regarding the calculation of Adjusted EBITDA.Oscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Rising SuccessLoop · Quick Win Big Bet1 hit
07
Oscar Health | Investor Conference Presentation Deck | 9 slidesOscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
08
Oscar Health | Investor Conference Presentation Deck | 9 slidesOscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
09
Oscar Health | Investor Conference Presentation Deck | 9 slidesOscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
01
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
03
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
04
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
05
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
06
Includes a map of US operations and two waterfall-style growth charts for membership and revenue.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Problem1 hit
07
P3 Health Partners | Investor Conference Presentation Deck | 19 slidesP3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
The chart shows a clear downward trend in medical costs for all cohorts compared to the rising benchmark.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
10
The chart uses dashed lines with markers for three distinct metrics. A callout box provides the key takeaway comparing internal performance to industry trends.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Loop · Cost Of Inaction1 hit